Efficacy and safety of sintilimab plus albumin-bound-paclitaxel in recurrent or metastatic cervical cancer: a multicenter, open-label, single-arm, phase II trial
- Resource Type
- Article
- Source
- In
eClinicalMedicine November 2023 65 - Subject
- Language
- ISSN
- 2589-5370